Covered recipient · General Payments record
EDWIN P ALYEA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$70,846.40
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $17,112.00 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $12,265.00 | 10 |
| Moderna TX, Inc. | $2,047.00 | 6 |
| BeiGene, Ltd. | $1,600.00 | 1 |
| National Marrow Donor Program | $1,200.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $935.00 | 01/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093915178 | CMS |
| AstraZeneca UK Limited | $55.00 | 02/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093936865 | CMS |
| AstraZeneca UK Limited | $2,145.00 | 03/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094052469 | CMS |
| AstraZeneca UK Limited | $5,445.00 | 04/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093946792 | CMS |
| AstraZeneca UK Limited | $1,595.00 | 05/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094017290 | CMS |
| AstraZeneca UK Limited | $55.00 | 06/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093904233 | CMS |
| AstraZeneca UK Limited | $440.00 | 07/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094004593 | CMS |
| AstraZeneca UK Limited | $165.00 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093957948 | CMS |
| AstraZeneca UK Limited | $1,045.00 | 09/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093924252 | CMS |
| AstraZeneca UK Limited | $385.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093970806 | CMS |
| BeiGene, Ltd. | $1,600.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120857569 | CMS |
| ModernaTX, Inc. | $390.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555459 | CMS |
| ModernaTX, Inc. | $195.00 | 03/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555465 | CMS |
| ModernaTX, Inc. | $390.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555475 | CMS |
| ModernaTX, Inc. | $292.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555479 | CMS |
| ModernaTX, Inc. | $390.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555523 | CMS |
| ModernaTX, Inc. | $390.00 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152555531 | CMS |
| National Marrow Donor Program | $600.00 | 04/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111767538 | CMS |
| National Marrow Donor Program | $600.00 | 10/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111767540 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.